Market Cap ₹636 Cr.
Stock P/E 8.7
P/B 1.7
Current Price ₹1114
Book Value ₹ 646.6
Face Value 10
52W High ₹1605
Dividend Yield 0.81%
52W Low ₹ 555
Albert David Ltd is an primarily India-based agency engaged within the production and trading of pharmaceuticals. The Company's plants are located at Gupta Lane, Kolkata; Meerut Road, Industrial Area, Ghaziabad, and New Industrial Area No.2, Mandideep.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Jun 2022 | Sep 2022 | Dec 2022 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 57 | 81 | 86 | 72 | 93 | 92 | 75 | 92 | 93 | 88 |
Other Income | 4 | 5 | 5 | 6 | -6 | 14 | 7 | 18 | 12 | 17 |
Total Income | 61 | 86 | 92 | 78 | 88 | 106 | 82 | 110 | 105 | 105 |
Total Expenditure | 50 | 71 | 73 | 64 | 81 | 78 | 66 | 79 | 77 | 80 |
Operating Profit | 11 | 15 | 19 | 13 | 7 | 28 | 16 | 31 | 28 | 25 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 9 | 13 | 16 | 11 | 4 | 26 | 14 | 29 | 27 | 23 |
Provision for Tax | 2 | 3 | 4 | 3 | 3 | 5 | 3 | 6 | 6 | 5 |
Profit After Tax | 7 | 10 | 13 | 8 | 2 | 20 | 11 | 23 | 20 | 19 |
Adjustments | 0 | 0 | -0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 |
Profit After Adjustments | 7 | 10 | 13 | 8 | 2 | 20 | 11 | 23 | 20 | 19 |
Adjusted Earnings Per Share | 12.8 | 18.3 | 22.2 | 14 | 3.1 | 35.3 | 18.5 | 41.2 | 35.6 | 32.8 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 265 | 291 | 322 | 323 | 295 | 290 | 317 | 321 | 247 | 314 | 342 | 348 |
Other Income | 2 | 1 | 2 | 2 | 16 | 10 | 21 | 7 | 17 | 16 | 15 | 54 |
Total Income | 267 | 291 | 324 | 325 | 311 | 300 | 339 | 328 | 265 | 329 | 357 | 402 |
Total Expenditure | 239 | 258 | 285 | 291 | 277 | 275 | 288 | 290 | 228 | 273 | 297 | 302 |
Operating Profit | 28 | 33 | 39 | 33 | 34 | 25 | 51 | 38 | 36 | 57 | 60 | 100 |
Interest | 4 | 4 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Depreciation | 11 | 11 | 15 | 9 | 8 | 8 | 7 | 8 | 8 | 9 | 9 | 7 |
Exceptional Income / Expenses | 0 | 0 | 0 | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 13 | 18 | 20 | 63 | 26 | 16 | 43 | 29 | 27 | 47 | 51 | 93 |
Provision for Tax | 5 | 6 | 7 | 15 | 10 | 6 | 16 | 10 | 5 | 12 | 15 | 20 |
Profit After Tax | 9 | 13 | 14 | 48 | 16 | 10 | 27 | 19 | 22 | 35 | 36 | 73 |
Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit After Adjustments | 9 | 13 | 14 | 48 | 16 | 10 | 27 | 19 | 22 | 35 | 36 | 73 |
Adjusted Earnings Per Share | 15 | 22 | 24 | 84.1 | 28 | 17.2 | 46.7 | 33.6 | 38.8 | 61.8 | 63.4 | 128.1 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 9% | 2% | 3% | 3% |
Operating Profit CAGR | 5% | 16% | 19% | 8% |
PAT CAGR | 3% | 24% | 29% | 15% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 95% | 35% | 23% | 25% |
ROE Average | 12% | 12% | 11% | 14% |
ROCE Average | 17% | 16% | 16% | 18% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 81 | 90 | 93 | 137 | 183 | 186 | 210 | 223 | 244 | 279 | 312 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 8 | 12 | 6 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Other Non-Current Liabilities | 34 | 47 | 8 | 8 | 9 | 15 | 20 | 25 | 25 | 14 | 12 |
Total Current Liabilities | 86 | 115 | 125 | 120 | 159 | 160 | 145 | 149 | 135 | 181 | 189 |
Total Liabilities | 210 | 265 | 231 | 265 | 351 | 361 | 376 | 398 | 405 | 475 | 512 |
Fixed Assets | 72 | 67 | 49 | 44 | 87 | 83 | 77 | 91 | 84 | 88 | 80 |
Other Non-Current Assets | 23 | 56 | 24 | 24 | 30 | 35 | 36 | 39 | 44 | 60 | 39 |
Total Current Assets | 115 | 141 | 158 | 196 | 234 | 243 | 263 | 268 | 278 | 327 | 393 |
Total Assets | 210 | 265 | 231 | 265 | 351 | 361 | 376 | 398 | 405 | 475 | 512 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 12 | 15 | 9 | 10 | 6 | -4 | 11 | 6 | 6 | 3 | 2 |
Cash Flow from Operating Activities | 20 | 21 | 28 | 68 | 20 | 30 | 32 | 30 | 37 | 40 | 11 |
Cash Flow from Investing Activities | -9 | -24 | -9 | -38 | -37 | -11 | -19 | -20 | -39 | -40 | -5 |
Cash Flow from Financing Activities | -8 | -2 | -18 | -18 | 7 | -5 | -17 | -10 | -2 | -2 | -6 |
Net Cash Inflow / Outflow | 3 | -5 | 1 | 12 | -10 | 14 | -4 | -0 | -4 | -1 | -1 |
Closing Cash & Cash Equivalent | 15 | 9 | 10 | 22 | -4 | 11 | 6 | 6 | 3 | 2 | 1 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 15 | 22.03 | 24.01 | 84.1 | 27.96 | 17.24 | 46.68 | 33.59 | 38.8 | 61.78 | 63.38 |
CEPS(Rs) | 33.81 | 41.4 | 51.01 | 99.86 | 41.13 | 31.91 | 58.97 | 47.03 | 53.22 | 77.21 | 78.36 |
DPS(Rs) | 4.5 | 5 | 5.5 | 5.5 | 5.5 | 5.5 | 6 | 7 | 6 | 9 | 9 |
Book NAV/Share(Rs) | 142.11 | 158.29 | 162.64 | 239.75 | 320.67 | 325.81 | 368.74 | 390.38 | 428.2 | 489.68 | 545.93 |
Core EBITDA Margin(%) | 8.54 | 9.93 | 11.03 | 9.38 | 5.91 | 5.1 | 8.77 | 9.04 | 7.4 | 12.38 | 12.33 |
EBIT Margin(%) | 5.58 | 6.76 | 6.96 | 19.49 | 8.63 | 5.46 | 13.12 | 8.87 | 10.84 | 14.51 | 14.23 |
Pre Tax Margin(%) | 4.41 | 5.58 | 6.06 | 18.88 | 8.34 | 5.14 | 12.86 | 8.58 | 10.54 | 14.3 | 14.07 |
PAT Margin (%) | 2.82 | 3.8 | 4.1 | 14.38 | 5.21 | 3.17 | 7.99 | 5.68 | 8.5 | 10.66 | 10.03 |
Cash Profit Margin (%) | 6.36 | 7.15 | 8.71 | 17.07 | 7.66 | 5.87 | 10.1 | 7.95 | 11.66 | 13.33 | 12.4 |
ROA(%) | 4.15 | 5.3 | 5.52 | 19.35 | 5.18 | 2.77 | 7.23 | 4.95 | 5.51 | 8.01 | 7.33 |
ROE(%) | 10.93 | 14.67 | 14.96 | 41.8 | 9.98 | 5.33 | 13.44 | 8.85 | 9.48 | 13.46 | 12.24 |
ROCE(%) | 14.45 | 17.79 | 18.22 | 46.48 | 14.29 | 7.94 | 20.6 | 13.74 | 11.99 | 18.1 | 17.1 |
Receivable days | 40.16 | 43.92 | 45.67 | 41.85 | 40.81 | 35.54 | 26.88 | 28.06 | 34.76 | 24.56 | 28 |
Inventory Days | 49.83 | 47.3 | 52 | 55.04 | 59.07 | 55.23 | 47.78 | 46.93 | 54.98 | 41.36 | 45.48 |
Payable days | 186.88 | 154.92 | 160.05 | 157.29 | 166.45 | 180.76 | 149.36 | 166.8 | 164.75 | 115.22 | 131.04 |
PER(x) | 6.01 | 5.27 | 11.45 | 3.55 | 11.4 | 21.14 | 8.44 | 9.58 | 9.71 | 8.61 | 8.08 |
Price/Book(x) | 0.63 | 0.73 | 1.69 | 1.25 | 0.99 | 1.12 | 1.07 | 0.82 | 0.88 | 1.09 | 0.94 |
Dividend Yield(%) | 4.99 | 4.31 | 2 | 1.84 | 1.73 | 1.51 | 1.52 | 2.18 | 1.59 | 1.69 | 1.76 |
EV/Net Sales(x) | 0.28 | 0.34 | 0.55 | 0.52 | 0.67 | 0.72 | 0.69 | 0.56 | 0.73 | 0.92 | 0.8 |
EV/Core EBITDA(x) | 2.7 | 2.96 | 4.58 | 5.04 | 5.8 | 8.3 | 4.3 | 4.76 | 4.97 | 5.1 | 4.54 |
Net Sales Growth(%) | 14.69 | 9.65 | 10.72 | 0.26 | -8.46 | -1.69 | 9.25 | 1.13 | -22.86 | 26.7 | 8.95 |
EBIT Growth(%) | 11.62 | 32.18 | 4.02 | 179.74 | -59.36 | -35.93 | 158.05 | -31.52 | -5.72 | 69.94 | 6.98 |
PAT Growth(%) | 12.2 | 46.91 | 8.96 | 250.33 | -66.76 | -38.32 | 170.71 | -28.05 | 15.52 | 59.23 | 2.6 |
EPS Growth(%) | 12.19 | 46.91 | 8.96 | 250.33 | -66.76 | -38.32 | 170.71 | -28.05 | 15.52 | 59.23 | 2.6 |
Debt/Equity(x) | 0.47 | 0.47 | 0.32 | 0.15 | 0.16 | 0.15 | 0 | 0.01 | 0.01 | 0.02 | 0.02 |
Current Ratio(x) | 1.33 | 1.23 | 1.27 | 1.64 | 1.48 | 1.52 | 1.81 | 1.81 | 2.05 | 1.81 | 2.08 |
Quick Ratio(x) | 0.83 | 0.85 | 0.85 | 1.23 | 1.16 | 1.25 | 1.5 | 1.52 | 1.79 | 1.59 | 1.81 |
Interest Cover(x) | 4.79 | 5.73 | 7.77 | 31.69 | 29.37 | 16.73 | 50.78 | 30.41 | 36 | 71.35 | 87.91 |
Total Debt/Mcap(x) | 0.73 | 0.64 | 0.19 | 0.12 | 0.17 | 0.13 | 0 | 0.01 | 0.01 | 0.02 | 0.02 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 61.64 | 61.96 | 61.99 | 61.99 | 61.99 | 62.04 | 62.04 | 62.04 | 62.04 | 62.13 |
FII | 0.71 | 0.75 | 0.64 | 0.61 | 0.57 | 0.57 | 0.65 | 0.57 | 0.7 | 0.98 |
DII | 3.18 | 3.18 | 3.18 | 2.98 | 2.84 | 2.8 | 2.3 | 1.9 | 1.67 | 1.67 |
Public | 34.47 | 34.11 | 34.19 | 34.42 | 34.59 | 34.59 | 35.01 | 35.48 | 35.59 | 35.22 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 | 0.35 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 |
DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
Public | 0.2 | 0.19 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 | 0.57 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About